[2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] (24Z,27Z,30Z,33Z)-hexatriaconta-24,27,30,33-tetraenoate

C76H126O6 — CID 165212561

IUPAC[2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] (24Z,27Z,30Z,33Z)-hexatriaconta-24,27,30,33-tetraenoate
SMILESCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC(COC(=O)CCCCCCC/C=C\CCCCC)COC(=O)CCCCCCCCCCCCCCCCCCCCCC/C=C\C/C=C\C/C=C\C/C=C\CC
InChIInChI=1S/C76H126O6/c1-4-7-10-13-16-19-22-25-27-29-31-32-33-34-35-36-37-38-39-40-41-42-43-44-46-47-49-51-54-57-60-63-66-69-75(78)81-72-73(71-80-74(77)68-65-62-59-56-53-24-21-18-15-12-9-6-3)82-76(79)70-67-64-61-58-55-52-50-48-45-30-28-26-23-20-17-14-11-8-5-2/h7-8,10-11,16-21,25-28,31-32,45,48,52,55,61,64,73H,4-6,9,12-15,22-24,29-30,33-44,46-47,49-51,53-54,56-60,62-63,65-72H2,1-3H3/b10-7-,11-8-,19-16-,20-17-,21-18-,27-25-,28-26-,32-31-,48-45-,55-52-,64-61-
InChIKeyFWVGUICLALXPSP-MEBLRPCRSA-N
MW1135.84 g/mol
LogP23.72
Rot. Bonds61

About [2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] (24Z,27Z,30Z,33Z)-hexatriaconta-24,27,30,33-tetraenoate

[2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] (24Z,27Z,30Z,33Z)-hexatriaconta-24,27,30,33-tetraenoate (PubChem CID 165212561) has the molecular formula C76H126O6 and a molecular weight of 1135.84 g/mol. Its IUPAC name is [2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] (24Z,27Z,30Z,33Z)-hexatriaconta-24,27,30,33-tetraenoate.

Molecular Properties

Compound Name[2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] (24Z,27Z,30Z,33Z)-hexatriaconta-24,27,30,33-tetraenoate
PubChem CID165212561
Molecular FormulaC76H126O6
Molecular Weight1135.84 g/mol
Exact Mass1134.96
IUPAC Name[2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] (24Z,27Z,30Z,33Z)-hexatriaconta-24,27,30,33-tetraenoate
SMILESCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC(COC(=O)CCCCCCC/C=C\CCCCC)COC(=O)CCCCCCCCCCCCCCCCCCCCCC/C=C\C/C=C\C/C=C\C/C=C\CC
InChIInChI=1S/C76H126O6/c1-4-7-10-13-16-19-22-25-27-29-31-32-33-34-35-36-37-38-39-40-41-42-43-44-46-47-49-51-54-57-60-63-66-69-75(78)81-72-73(71-80-74(77)68-65-62-59-56-53-24-21-18-15-12-9-6-3)82-76(79)70-67-64-61-58-55-52-50-48-45-30-28-26-23-20-17-14-11-8-5-2/h7-8,10-11,16-21,25-28,31-32,45,48,52,55,61,64,73H,4-6,9,12-15,22-24,29-30,33-44,46-47,49-51,53-54,56-60,62-63,65-72H2,1-3H3/b10-7-,11-8-,19-16-,20-17-,21-18-,27-25-,28-26-,32-31-,48-45-,55-52-,64-61-
InChIKeyFWVGUICLALXPSP-MEBLRPCRSA-N
XLogP23.72
TPSA78.90 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds61
Heavy Atoms82
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001135.84
LogP ≤ 523.72
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze [2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] (24Z,27Z,30Z,33Z)-hexatriaconta-24,27,30,33-tetraenoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] (24Z,27Z,30Z,33Z)-hexatriaconta-24,27,30,33-tetraenoate?
The IUPAC name of [2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] (24Z,27Z,30Z,33Z)-hexatriaconta-24,27,30,33-tetraenoate (CID 165212561) is [2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] (24Z,27Z,30Z,33Z)-hexatriaconta-24,27,30,33-tetraenoate.
What is the SMILES notation for [2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] (24Z,27Z,30Z,33Z)-hexatriaconta-24,27,30,33-tetraenoate?
The canonical SMILES for [2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] (24Z,27Z,30Z,33Z)-hexatriaconta-24,27,30,33-tetraenoate is CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC(COC(=O)CCCCCCC/C=C\CCCCC)COC(=O)CCCCCCCCCCCCCCCCCCCCCC/C=C\C/C=C\C/C=C\C/C=C\CC.
What is the InChIKey of [2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] (24Z,27Z,30Z,33Z)-hexatriaconta-24,27,30,33-tetraenoate?
The InChIKey is FWVGUICLALXPSP-MEBLRPCRSA-N. The full InChI is InChI=1S/C76H126O6/c1-4-7-10-13-16-19-22-25-27-29-31-32-33-34-35-36-37-38-39-40-41-42-43-44-46-47-49-51-54-57-60-63-66-69-75(78)81-72-73(71-80-74(77)68-65-62-59-56-53-24-21-18-15-12-9-6-3)82-76(79)70-67-64-61-58-55-52-50-48-45-30-28-26-23-20-17-14-11-8-5-2/h7-8,10-11,16-21,25-28,31-32,45,48,52,55,61,64,73H,4-6,9,12-15,22-24,29-30,33-44,46-47,49-51,53-54,56-60,62-63,65-72H2,1-3H3/b10-7-,11-8-,19-16-,20-17-,21-18-,27-25-,28-26-,32-31-,48-45-,55-52-,64-61-.
What are the key properties of [2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] (24Z,27Z,30Z,33Z)-hexatriaconta-24,27,30,33-tetraenoate?
[2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] (24Z,27Z,30Z,33Z)-hexatriaconta-24,27,30,33-tetraenoate has a molecular weight of 1135.84 g/mol, XLogP of 23.72, 61 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for [2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-[(Z)-pentadec-9-enoyl]oxypropyl] (24Z,27Z,30Z,33Z)-hexatriaconta-24,27,30,33-tetraenoate is sourced from PubChem (CID 165212561), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).